Dynamic mechanisms of non-classical antagonism by competitive AT1 receptor antagonists

Trends in Pharmacological Sciences

Volumn 21, Issue 10, 2000, Pages 376-381

  Lew, Michael J ^a   Ziogas, James ^a   Christopoulos, Arthur ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; G PROTEIN COUPLED RECEPTOR; LOSARTAN; PARTIAL AGONIST;

ANIMAL CELL; ANIMAL TISSUE; AORTA; CHO CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; KINETICS; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REVIEW; TACHYPHYLAXIS;

ANGIOTENSIN II; ANIMAL; CHO CELLS; HAMSTERS; MODELS, CHEMICAL; RECEPTORS, ANGIOTENSIN;

EID: 0034306496     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01523-6     Document Type: Review

References (33)

1. The cholecystokinin-B receptor antagonist L-740,093 produces an insurmountable antagonism of CCK-4 stimulated functional response in cells expressing the human CCK-B receptor
2. 2-receptor blockers intheguinea pig papillary muscle
3. The assessment of antagonist potency under conditions of transient response kinetics
4. Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation
5. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery
6. Pharmacological characterization of antagonists of the C5a receptor
7. ICI 147,798; a slowly dissociable β adrenoceptor antagonist that causes insurmountable β-1 and surmountable β-2 adrenoceptor antagonism in isolated tissues
8. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657
9. 2+ mobilization bymuscarinic antagonists
10. The kinetics of action of acetylcholine antagonists in smooth muscle
11. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629
12. 1 receptor antagonists; the role of tight antagonist binding
13. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies
14. Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action
15. The immediate pressor response to saralasinin man; a test of angiotensin II receptor vacancy
16. Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects
17. Phosphorylation of the angiotensin II (AT(1A)) receptor carboxyl terminus; a role in receptor endocytosis
18. Angiotensin II surface receptor coupling to inositol trisphosphate formation in vascular smooth muscle cells
19. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor
20. Agonist-antagonist interactions at angiotensin receptors; application of a two-state receptor model
21. 1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries
22. 1) receptor function
23. Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate; morphological analysis of angiotensin II processing in isolated vascular strips
24. 2+-sensitivity of the contractile apparatus during angiotensin II-induced desensitization in the rabbit femoral artery
25. +-depolarized rabbit femoral artery
26. A study of the 'desensitization' produced by acetylcholine at the motor end-plate
27. Desensitization, two-state receptors and pharmacological parameters
28. Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve
29. 1 receptor antagonist, losartan
30. 3H]methylscopolamine from isolated guinea pig atria is controlled by diffusion and rebinding
31. The rate of action of atropine
32. Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta
33. Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state